REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
28 hedge funds and large institutions have $21M invested in REVIVA PHARMA HLDGS INC in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 11 closing their positions.
209% more call options, than puts
Call options by funds: $2.19M | Put options by funds: $709K
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
0.05% more ownership
Funds ownership: 0.94% → 1% (+0.05%)
22% less funds holding
Funds holding: 36 → 28 (-8)
23% less capital invested
Capital invested by funds: $27.1M → $21M (-$6.13M)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$3.7M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.28M |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$2M |
| 4 |
Millennium Management
New York
|
+$209K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$198K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$9.08M |
| 2 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$1.01M |
| 3 |
Man Group
London,
United Kingdom
|
-$253K |
| 4 |
Two Sigma Investments
New York
|
-$214K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$196K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CG
26
Cutler Group
San Francisco,
California
| $11K | – | – | – |
|
|
AIC
27
Archer Investment Corporation
Carmel,
Indiana
| $1.89K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $662 | +$158 | +2 | +29% |
|
|
AC
29
Armistice Capital
New York
| – | -$9.08M | -88,200 | Closed |
|
|
RA
30
Rosalind Advisors
Toronto,
Ontario, Canada
| – | -$1.01M | -9,815 | Closed |
|
|
31
Man Group
London,
United Kingdom
| – | -$253K | -2,460 | Closed |
|
32
Citadel Advisors
Miami,
Florida
| – | -$179K | -2,263 | Closed |
|
33
Simplex Trading
Chicago,
Illinois
| – | -$179K | -2,261 | Closed |
|
|
34
Two Sigma Investments
New York
| – | -$214K | -2,080 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$196K | -1,902 | Closed |
|
|
VF
36
Virtu Financial
New York
| – | -$78K | -762 | Closed |
|
|
IWC
37
Integrated Wealth Concepts
Waltham,
Massachusetts
| – | -$51.5K | -500 | Closed |
|
38
Belvedere Trading
Chicago,
Illinois
| – | -$17.1K | -166 | Closed |
|
RVPH Hedge Fund Activity: Q1 2024 in Review
28 of the 6,947 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q1 2024, worth a combined $21M — down 23% from $27.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of RVPH and 3 opened new positions — a net loss of 8 holders — while 6 trimmed existing stakes and 11 added.
The largest buyer was Woodline Partners, adding an estimated $3.7M. The largest seller was Armistice Capital, exiting entirely with an estimated $9.08M sold.
- 28 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q1 2024, down from 36 in Q4 2023.
- Funds reported $21M of REVIVA PHARMA HLDGS INC stock for Q1 2024, down 23% quarter-over-quarter.
- 3 funds opened new REVIVA PHARMA HLDGS INC positions in Q1 2024 and 11 closed out, a net change of -8 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q1 2024 was Woodline Partners, an estimated $3.7M added.
- The largest REVIVA PHARMA HLDGS INC seller in Q1 2024 was Armistice Capital, an estimated $9.08M sold.
Based on aggregated 13F filings for Q1 2024.